T. Rowe Price Investment Management, Inc. Procept Bio Robotics Corp Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,747,089 shares of PRCT stock, worth $142 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,747,089
Previous 2,939,919
40.57%
Holding current value
$142 Million
Previous $145 Million
26.54%
% of portfolio
0.07%
Previous 0.09%
Shares
8 transactions
Others Institutions Holding PRCT
# of Institutions
214Shares Held
36.3MCall Options Held
251KPut Options Held
101K-
Vanguard Group Inc Valley Forge, PA4.71MShares$382 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$283 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.81MShares$147 Million0.04% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.37MShares$111 Million0.53% of portfolio
-
Loomis Sayles & CO L P1.26MShares$102 Million0.11% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.62B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...